Back to search

Article

Association Between Tumor Mutation Burden (TMB) and immune microenvironment in lung squamous cell carcinoma

2020-11-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background </bold>Tumor mutational burden (TMB) is an emerging biomarker for selecting patients with non-small cell lung cancer (NSCLC) for immunotherapy. And many studies have revealed high-TMB may be significantly associated with response to PD-1 and PD-L1 blockade immunotherapy.<bold>Methods </bold>The RNA-seq transcriptome profiling, simple nucleotide variation and correspondi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
65945359-95fa-5b3b-be98-78fbb08a0c49
DOI
10.21203/rs.3.rs-110577/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Association Between Tumor Mutation Burden (TMB) and immune microenvironment in lung squamous cell carcinomaDOI 10.21203/rs.3.rs-110577/v1
Select a neighboring publication to make it the new centre.